Skip to search formSkip to main contentSkip to account menu

Gangliosidosis GM1

Known as: Gangliosidosis G(M1), Beta-Galactosidase-1 Deficiency Disease, Beta-Galactosidosis 
An autosomal recessive neurodegenerative disorder caused by the absence or deficiency of BETA-GALACTOSIDASE. It is characterized by intralysosomal… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
A major objective of next generation reusable launch vehicle (RLV) programs includes significant improvements in vehicle safety… 
2007
2007
SummaryDiagnosis of GM1 gangliosidosis (OMIM 230500) is usually based on the presence of physical signs of storage such as coarse… 
2004
2004
Two children with GM-2 gangliosidosis type 0 (Sandhoff's disease) followed up by MRI at 1.5 Tesla for 1.8 years are reported. One… 
2001
2001
A deficiency of lysosomal β-d-galactosidase (βG; EC 3.2.1.23) is the primary defect in the three clinical forms (infantile… 
Review
1997
Review
1997
Three unrelated North American cases with slowly progressive forms of GM1 gangliosidosis were found to have two unique point… 
1997
1997
GM1 gangliosidosis (McKusick 230500) is characterized biochemically by a deficiency of the lysosomal enzyme β -galactosidase (EC… 
Review
1995
Review
1995
beta-galactosidosis is a lysosomal storage disorder caused by a deficiency of acid beta-galactosidase, including to autosomal… 
1989
1989
A patient with severe deficiency of β‐galactosidase, who developed skin lesions of angiokeratoma corporis diffusum between the… 
1975
1975
Pathological, histochemical and ultrastructural studies on 3 siblings with GM1 gangliosidosis type II are reported. These studies…